Pharmaceutical News

RSS

Symptomatic pharmacotherapy of elderly people should be regularly monitored

The prevalence of using antidepressants and proton pump inhibitors increases after the diagnosis of Alzheimer’s disease, according to a doctoral dissertation from the University of Eastern Finland.

26 Mar 2019

Aspirin could be used to treat patients with severe tuberculosis infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.

26 Mar 2019

Study evaluates prescribing of preventive drugs at the end of life in older adults with cancer

A new study reveals that preventive medications--such as those to lower blood pressure or cholesterol, or to protect bone health, among others--are commonly prescribed during the last year of life of older adults with cancer, even though they are unlikely to provide meaningful benefits.

25 Mar 2019

Bisphosphonates to treat osteoporosis appears to be beneficial for all women

In recent years, women who start taking bisphosphonates to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report.

25 Mar 2019

Long term opioid medications impacts production of important hormones

Many people who use opioid medications long term do not produce enough testosterone or another important hormone, cortisol, according to a new study.

25 Mar 2019

New guideline focuses on strategies to improve health of older adults with diabetes

Simplifying medication regimens and tailoring glycemic targets in older adults with diabetes improves adherence and avoids treatment-related complications, according to a Clinical Practice Guideline issued today by the Endocrine Society.

25 Mar 2019

Inherited form of rickets improves more with new injectable medicine than conventional therapy

Burosumab, a new injectable medicine to treat X-linked hypophosphatemia (XLH), an inherited form of rickets, demonstrates superior improvements in rickets and other outcomes compared with conventional therapy in an international, phase 3 clinical trial in children.

25 Mar 2019

Long-term use of inexpensive weight-loss drug may be safe and effective

An inexpensive weight-loss drug approved 60 years ago for only short-term use also may be safe and effective for longer-term treatment, according to a study conducted by researchers at Wake Forest Baptist Health and the Patient Outcomes Research to Advance Learning network.

22 Mar 2019

Repurposing drugs to outsmart cancers

In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which may open new drug therapies to patients regardless of tumor type.

22 Mar 2019

Presence of bacteria in urine does not always point to infection, shows study

Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

22 Mar 2019

Alzheimer's patients using antiepileptic drugs have twice the risk of pneumonia, study shows

People with Alzheimer's disease using antiepileptic drugs have twice the risk of pneumonia compared to non-users, a new study from the University of Eastern Finland shows.

21 Mar 2019

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

Under Australia's Pharmaceutical Benefits Scheme (PBS), soon many of the rare diseases and their treatments are set to become cheaper.

21 Mar 2019

FDA approves brexanolone, first drug developed to treat postpartum depression

Approximately 1 in 9 women in the United States experiences symptoms of postpartum depression, according to the Centers for Disease Control and Prevention.

21 Mar 2019

New technique detects fake drugs from video taken as sample undergoes disturbance

If we could tell authentic from counterfeit or adulterated drugs and foods just by looking at them, we could save money and lives every year, especially in the developing world, where the problem is worst.

21 Mar 2019

Innovative in vitro method to develop easy-to-swallow medicine for children and older people

Scientists at the University of Surrey and University College London have revealed an innovative in vitro method that can help to develop easy to swallow medicine for children and older people.

21 Mar 2019

Most pills contain common allergens, warn experts

Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.

20 Mar 2019

Worryingly long wait for NHS cancer patients

Around a fourth of NHS cancer patients have to wait a worryingly long amount of time to start treatment, according to a new NHS England report.

20 Mar 2019

FDA approves first drug for treatment of postpartum depression in adult women

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous use for the treatment of postpartum depression in adult women. This is the first drug approved by the FDA specifically for PPD.

20 Mar 2019

Newly discovered parameters offer more control over efficient release of drugs

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs. This gives more control over the slow and steady release of drugs in patients.

20 Mar 2019

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes, shingles, fibromyalgia and other serious conditions.

19 Mar 2019